Storage solutions to improve grafts preservation and longevity in coronary artery bypass grafting surgery: hype or hope?
Journal
Current opinion in cardiology
ISSN: 1531-7080
Titre abrégé: Curr Opin Cardiol
Pays: United States
ID NLM: 8608087
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
entrez:
16
8
2021
pubmed:
17
8
2021
medline:
22
9
2021
Statut:
ppublish
Résumé
Saphenous vein grafts (SVGs) remain the most-commonly used conduits for coronary artery bypass grafting (CABG).Significant rates of vein graft failure (VGF) remain a limitation of their use as this diminishes the long-term benefits of CABG. The choice of intraoperative SVGs preservation solution is believed to have an impact on graft patency; however, the superiority of one solution over the others remains in question. In the present review, we describe the pathophysiological mechanisms underlying the different phases of VGF. We also reviewed the most recent literature comparing and evaluating the efficacy of various storage solutions. These include heparinized saline, autologous heparinized blood, buffered solutions, and crystalloid cardioplegia. It is clear that the composition of the SVGs storage solution has an impact on vessel wall structure and function. There is a lack of translational and clinical research on the topic; thus, conclusions cannot be drawn regarding the superiority of one solution over the others in terms of VGF. Future research needs to be conducted to address this gap in the literature in order to make meaningful evidence-based recommendations on intraoperative graft storage.
Identifiants
pubmed: 34397467
doi: 10.1097/HCO.0000000000000875
pii: 00001573-202109000-00016
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
616-622Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Gupta S, Belley-Cote EP, Panchal P, et al. Antiplatelet therapy and coronary artery bypass grafting: a systematic review and network meta-analysis. Interact Cardiovasc Thorac Surg 2020; 31:354–363.
Shroyer AL, Hattler B, Wagner TH, et al. Five-year outcomes after on-pump and off-pump coronary-artery bypass. New Engl J Med 2017; 377:623–632.
Lopes RD, Williams JB, Mehta RH, et al. Edifoligide and long-term outcomes after coronary artery bypass grafting: PREVENT IV 5-year results. Am Heart J 2012; 164:379–386. e1.
Zhao Q, Zhu Y, Xu Z, et al. Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial. JAMA 2018; 319:1677–1686.
Kulik A, Voisine P, Mathieu P, et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE Randomized Trial. Ann Thorac Surg 2011; 92:1284–1291.
Gaudino M, Benedetto U, Fremes S, et al. Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery. New Engl J Med 2018; 378:2069–2077.
Gaudino M, Tondi P, Benedetto U, et al. Radial artery as a coronary artery bypass conduit: 20-year results. J Am Coll Cardiol 2016; 68:603–610.
Buxton Brian F, Hayward Philip A, Raman J, et al. Long-term results of the RAPCO Trials. Circulation 2020; 142:1330–1338.
Deb S, Cohen EA, Singh SK, et al. Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study). J Am Coll Cardiol 2012; 60:28–35.
Harskamp RE, Lopes RD, Baisden CE, et al. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg 2013; 257:824–833.
Gaudino M, Antoniades C, Benedetto U, et al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation 2017; 136:1749–1764.
Tsakok M, Montgomery-Taylor S, Tsakok T. Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function? Interact Cardiovasc Thorac Surg 2012; 15:720–725.
Woodward LC, Antoniades C, Taggart DP. Intraoperative vein graft preservation: what is the solution? Ann Thorac Surg 2016; 102:1736–1746.
Ali WB, Bouhout I, Perrault LP. The effect of storage solutions, gene therapy, and antiproliferative agents on endothelial function and saphenous vein graft patency. J Cardiac Surg 2018; 33:235–242.
Shukla N, Jeremy JY. Pathophysiology of saphenous vein graft failure: a brief overview of interventions. Curr Opin Pharmacol 2012; 12:114–120.
McKavanagh P, Yanagawa B, Zawadowski G, Cheema A. Management and prevention of saphenous vein graft failure: a review. Cardiol Ther 2017; 6:203–223.
Pachuk CJ, Rushton-Smith SK, Emmert MY. Intraoperative storage of saphenous vein grafts in coronary artery bypass grafting. Expert Rev Med Devices 2019; 16:989–997.
Chen S-W, Chu Y, Wu VC-C, et al. Microenvironment of saphenous vein graft preservation prior to coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2019; 28:71–78.
Perrault LP, Carrier M, Voisine P, et al. Sequential multidetector computed tomography assessments after venous graft treatment solution in coronary artery bypass grafting. J Thorac Cardiovasc Surg 2021; 161:96–106. e2.
Papakonstantinou NA, Sykaras AG, Vourlakou C, et al. Cardioplegic storage solution: is it the guardian of saphenous vein graft endothelium? J Cardiac Surg 2020; 35:996–1003.
Harskamp RE, Alexander JH, Schulte PJ, et al. Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV Randomized Clinical Trial. JAMA Surg 2014; 149:798–805.
Fouquet O, Blossier J-D, Dang Van S, et al. Do storage solutions protect endothelial function of arterialized vein graft in an experimental rat model? J Cardiothorac Surg 2020; 15:34.
Wilbring M, Ebner A, Schoenemann K, et al. Heparinized blood better preserves cellular energy charge and vascular functions of intraoperatively stored saphenous vein grafts in comparison to isotonic sodium-chloride-solution. Clin Hemorheol Microcirc 2013; 55:445–455.
Thatte HS, Biswas KS, Najjar SF, et al. Multiphoton microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg 2003; 75:1145–1152.
Wise ES, Hocking KM, Eagle S, et al. Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft. Surgery 2015; 158:537–546.
Caliskan E, Pachuk CJ, Perrault LP, Emmert MY. Preservation solutions to improve graft patency: the devil is in the detail. J Cardiothorac Surg 2020; 15:228.
Haime M, McLean RR, Kurgansky KE, et al. Relationship between intra-operative vein graft treatment with DuraGraft( or saline and clinical outcomes after coronary artery bypass grafting. Expert Rev Cardiovasc Ther 2018; 16:963–970.
University of Wisconsin Solution - an overview | ScienceDirect Topics [Internet]. Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/university-of-wisconsin-solution . [Accessed 2 February 2021].
Bas M, Luther B, Knopf A, et al. Preservation of endothelial and smooth muscle function of human saphenous vein transplants. Exp Clin Transplant 2016; 14:86–92.
HTK Solution - an overview | ScienceDirect Topics [Internet]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/htk-solution . [Accessed 3 February 2021].
Veres G, Hegedűs P, Barnucz E, et al. TiProtec preserves endothelial function in a rat model. J Surg Res 2016; 200:346–355.
Wilbring M, Tugtekin SM, Zatschler B, et al. Preservation of endothelial vascular function of saphenous vein grafts after long-time storage with a recently developed potassium-chloride and N-acetylhistidine enriched storage solution. Thorac Cardiovasc Surg 2013; 61:656–662.
Celsior - an overview | ScienceDirect Topics [Internet]. Available from: https://www.sciencedirect.com/topics/medicine-and-dentistry/celsior . [Accessed 3 February 2021].
Shokri M, Moradpour R, Shafaroudi MM, et al. Comparing the effects of krebs plus verapamil solution on endothelial function of harvested human greater saphenous vein with heparinized blood, an in vitro study. Med Arch 2017; 71:188–192.